There are no data to indicate that either laboratory or imaging tests or any tumor markers, such as cancer antigen 15–3 (CA15-3) or carcinoembryonic antigen (CEA), result in a survival benefit (I, D). This evidence concerns the gene CEACAM5 and cancer.